A. Marilyn Leitch

9.0k citations

32 papers · 5.5k indexed · 4 hit papers · h-index 22

Cancer Research top 0.2%
Pathology and Forensic Medicine top 0.2%
Surgery top 1%
Oncology top 1%
Molecular Biology top 10%

Co-authors: Kelly K. Hunt Linda McCall Armando E. Giuliano Peter Blumencranz Peter D. Beitsch Pat W. Whitworth Karla V. Ballman Sukamal Saha
Topics: Breast Cancer Treatment Studies (23 papers)Breast Lesions and Carcinomas (14 papers)Breast Implant and Reconstruction (7 papers)
Cited by: Cancer Research Pathology and Forensic Medicine Oncology
Journals: Nature JAMA Journal of Clinical Oncology
Partner nations: United States Switzerland India

In The Last Decade

A. Marilyn Leitch

31 papers receiving 5.4k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Effect of Axillary Dissection vs No Axillary Dissection on 10-Year Overall Survival Among Women With Invasive Breast Cancer and Sentinel Node Metastasis

2017 1.1k citations Armando E. Giuliano, Karla V. Ballman et al. JAMA profile →
Oxidative stress inhibits distant metastasis by human melanoma cells

2015 929 citations Elena Piskounova, Michalis Agathocleous et al. Nature profile →
Locoregional Recurrence After Sentinel Lymph Node Dissection With or Without Axillary Dissection in Patients With Sentinel Lymph Node Metastases

2010 879 citations Armando E. Giuliano, Linda McCall et al. Annals of Surgery profile →
Surgical Complications Associated With Sentinel Lymph Node Dissection (SLND) Plus Axillary Lymph Node Dissection Compared With SLND Alone in the American College of Surgeons Oncology Group Trial Z0011

2007 660 citations Anthony Lucci, Linda McCall et al. Journal of Clinical Oncology profile →

Peers

Countries citing papers authored by A. Marilyn Leitch

Since Specialization

Citations

This map shows the geographic impact of A. Marilyn Leitch's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A. Marilyn Leitch with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A. Marilyn Leitch more than expected).

Fields of papers citing papers by A. Marilyn Leitch

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by A. Marilyn Leitch. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A. Marilyn Leitch. The network helps show where A. Marilyn Leitch may publish in the future.

Co-authorship network of co-authors of A. Marilyn Leitch

This figure shows the co-authorship network connecting the top 25 collaborators of A. Marilyn Leitch. A scholar is included among the top collaborators of A. Marilyn Leitch based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with A. Marilyn Leitch. A. Marilyn Leitch is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Genomic characterization of HER2-positive breast cancer and response to neoadjuvant trastuzumab and chemotherapy—results from the ACOSOG Z1041 (Alliance) trial 2017 ·Annals of Oncology ·Robert Lesurf,Obi L. Griffith,Malachi Griffith,Jasreet Hundal,Lee Trani,Mark A. Watson,Rebecca Aft,Matthew J. Ellis,(unknown),Vera J. Suman,Funda Meric‐Bernstam,A. Marilyn Leitch,Judy C. Boughey,Gary Unzeitig,Aman U. Buzdar,Kelly K. Hunt,Elaine R. Mardis	47
2	Effect of Axillary Dissection vs No Axillary Dissection on 10-Year Overall Survival Among Women With Invasive Breast Cancer and Sentinel Node Metastasisbreakdown → 2017 ·JAMA ·Armando E. Giuliano,Karla V. Ballman,Linda McCall,Peter D. Beitsch,Meghan B. Brennan,Pond R. Kelemen,David W. Ollila,Nora Hansen,Pat W. Whitworth,Peter Blumencranz,A. Marilyn Leitch,Sukamal Saha,Kelly K. Hunt,Monica Morrow	1080
3	Isolated Contralateral Axillary Lymph Node Involvement in Breast Cancer Represents a Locally Advanced Disease Not Distant Metastases 2017 ·Clinical Breast Cancer ·(unknown),Mary Ann Sanders,Barbara Haley,A. Marilyn Leitch,Sunati Sahoo	25
4	Locoregional Recurrence After Sentinel Lymph Node Dissection With or Without Axillary Dissection in Patients With Sentinel Lymph Node Metastases 2016 ·Annals of Surgery ·Armando E. Giuliano,Karla V. Ballman,Linda McCall,Peter D. Beitsch,Pat W. Whitworth,Peter Blumencranz,A. Marilyn Leitch,Sukamal Saha,Monica Morrow,Kelly K. Hunt	336
5	Oxidative stress inhibits distant metastasis by human melanoma cellsbreakdown → 2015 ·Nature ·Elena Piskounova,Michalis Agathocleous,Malea M. Murphy,Zeping Hu,(unknown),Zhiyu Zhao,A. Marilyn Leitch,Timothy M. Johnson,Ralph J. DeBerardinis,Sean J. Morrison	929
6	Impact of weight change during neoadjuvant chemotherapy on pathologic response in triple‐negative breast cancer 2015 ·Cancer Medicine ·(unknown),(unknown),(unknown),James F. Huth,A. Marilyn Leitch,Aeisha Rivers,(unknown),Roshni Rao	13
7	Fluorouracil, epirubicin, and cyclophosphamide (FEC-75) followed by paclitaxel plus trastuzumab versus paclitaxel plus trastuzumab followed by FEC-75 plus trastuzumab as neoadjuvant treatment for patients with HER2-positive breast cancer (Z1041): a randomised, controlled, phase 3 trial 2013 ·The Lancet Oncology ·Aman U. Buzdar,Vera J. Suman,Funda Meric‐Bernstam,A. Marilyn Leitch,Matthew J. Ellis,Judy C. Boughey,Gary Unzeitig,Melanie Royce,Linda McCall,Michael S. Ewer,Kelly K. Hunt	120
8	Association of Occult Metastases in Sentinel Lymph Nodes and Bone Marrow With Survival Among Women With Early-Stage Invasive Breast Cancer 2011 ·JAMA ·Armando E. Giuliano,Debra Hawes,Karla V. Ballman,Pat W. Whitworth,Peter Blumencranz,Douglas S. Reintgen,Monica Morrow,A. Marilyn Leitch,Kelly K. Hunt,Linda McCall,Andrea Abati,Rick Cote	178
9	Impact of Routine Cavity Shave Margins on Breast Cancer Re-excision Rates 2010 ·Annals of Surgical Oncology ·(unknown),(unknown),Xian‐Jin Xie,Jingsheng Yan,David Euhus,Yan Peng,Venetia Sarode,Amy Moldrem,A. Marilyn Leitch,Valerie Andrews,(unknown),Roshni Rao	67
10	A phase II study evaluating the role of sentinel lymph node surgery and axillary lymph node dissection following preoperative chemotherapy in women with node-positive breast cancer (T1-4, N1-2, M0) at initial diagnosis: ACOSOG Z1071. 2010 ·Journal of Clinical Oncology ·(unknown),Huong T. Le‐Petross,Vera J. Suman,Bruce G. Haffty,A. Marilyn Leitch,(unknown),David R. Byrd,Thomas A. Buchholz,W. Fraser Symmans,(unknown)	1
11	Locoregional Recurrence After Sentinel Lymph Node Dissection With or Without Axillary Dissection in Patients With Sentinel Lymph Node Metastasesbreakdown → 2010 ·Annals of Surgery ·Armando E. Giuliano,Linda McCall,Peter D. Beitsch,Pat W. Whitworth,Peter Blumencranz,A. Marilyn Leitch,Sukamal Saha,Kelly K. Hunt,Monica Morrow,Karla V. Ballman	879
12	False-Positive Sentinel Lymph Nodes in Breast Cancer Patients Caused by Benign Glandular Inclusions 2008 ·American Journal of Clinical Pathology ·Yan Peng,Raheela Ashfaq,(unknown),A. Marilyn Leitch,Kyle Molberg	16
13	Society of Surgical Oncology: Position Statement on Prophylactic Mastectomy. Approved by the Society of Surgical Oncology Executive Council, March 2007 2007 ·Annals of Surgical Oncology ·Armando E. Giuliano,Susan K. Boolbol,Amy C. Degnim,Henry M. Kuerer,A. Marilyn Leitch,Monica Morrow	91
14	Surgical Complications Associated With Sentinel Lymph Node Biopsy: Results From a Prospective International Cooperative Group Trial 2006 ·Annals of Surgical Oncology ·Lee G. Wilke,Linda McCall,Katherine E. Posther,Pat W. Whitworth,Douglas S. Reintgen,A. Marilyn Leitch,Sheryl G. A. Gabram,Anthony Lucci,Charles E. Cox,Kelly K. Hunt,James E. Herndon,Armando E. Giuliano	443
15	Clinical Relevance of Reverse Transcriptase-Polymerase Chain Reaction for the Detection of Axillary Lymph Node Metastases in Breast Cancer 2003 ·Annals of Surgical Oncology ·Masahiro Sakaguchi,Arvind K. Virmani,(unknown),George N. Peters,A. Marilyn Leitch,Hossein Saboorian,Adi F. Gazdar,David Euhus	27
16	Loss of Heterozygosity in Benign Breast Epithelium in Relation to Breast Cancer Risk 2002 ·JNCI Journal of the National Cancer Institute ·David Euhus,Leslie Cler,Narayan Shivapurkar,Sara Milchgrub,George N. Peters,A. Marilyn Leitch,(unknown),Adi F. Gazdar	32
17	Validating the performance of the mammary sentinel lymph node team 2002 ·Journal of Surgical Oncology ·David Euhus,George N. Peters,A. Marilyn Leitch,Hossein Saboorian,Dana Mathews,William Erdman,(unknown),(unknown)	10
18	Characterization of paired tumor and non-tumor cell lines established from patients with breast cancer 1998 ·International Journal of Cancer ·Adi F. Gazdar,(unknown),Arvind K. Virmani,Lauren Gollahon,Masahiro Sakaguchi,(unknown),(unknown),(unknown),(unknown),Ignacio I. Wistuba,Gail E. Tomlinson,Vijay S. Tonk,Raheela Ashfaq,A. Marilyn Leitch,John D. Minna,Jerry W. Shay	242
19	Controversies in breast cancer screening 1995 ·Cancer ·A. Marilyn Leitch	21
20	Breast cancer in a county hospital population: Impact of breast screening on stage of presentation 1994 ·Annals of Surgical Oncology ·A. Marilyn Leitch,(unknown)	10

About A. Marilyn Leitch

A. Marilyn Leitch is a scholar working on Cancer Research, Pathology and Forensic Medicine and Oncology, having authored 32 papers that have together received 5.5k indexed citations. Recurring topics across this work include Breast Cancer Treatment Studies (23 papers), Breast Lesions and Carcinomas (14 papers) and Breast Implant and Reconstruction (7 papers). The work is most often cited by research in Cancer Research (4.0k citations), Pathology and Forensic Medicine (2.5k citations) and Oncology (2.1k citations). A. Marilyn Leitch has collaborated with scholars based in United States, Switzerland and India. Frequent co-authors include Kelly K. Hunt, Linda McCall, Armando E. Giuliano, Peter Blumencranz, Peter D. Beitsch, Pat W. Whitworth, Karla V. Ballman, Sukamal Saha, Monica Morrow and Douglas S. Reintgen. Their work appears in journals such as Nature, JAMA and Journal of Clinical Oncology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact